Search - tctmd.com

Displaying 41 - 60 of 221

Sort: Relevancy | Date

News Conference News TCT 2023

Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis

Todd Neale

November 02, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2023

Shelley Wood

November 01, 2023

Presentation TCT 2023

TCT 128: Treatment of Coronary Artery Disease with Sirolimus- Versus Paclitaxel-Coated Balloons

Presenter: Matthias Bossard

October 25, 2023

Presentation TCT 2023

Prevail Paclitaxel Coated Balloon

Presenter: Jack Tan

October 25, 2023

Presentation TCT 2023

TCT 743: Long-term Clinical Outcomes of Paclitaxel-Coated Balloon Coronary Angioplasty: Data from the IRIS-DEB Registry

Presenter: Young-Sun Park

October 25, 2023

News Conference News TCT 2023

Comparing DCBs in De Novo CAD: Drugs, Design Matter

Caitlin E. Cox

October 25, 2023

News Conference News TCT 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Todd Neale

October 25, 2023

Presentation TCT 2023

TCT 286: Comparison of Downstream Effect and Arterial Responses Among Sirolimus- and Paclitaxel-coated Balloons in Swine Heart Model

Presenter: Teruo Sekimoto

October 25, 2023

Presentation TCT 2023

Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Drug-Eluting Stent In-Stent Restenosis: A Prospective, Multicenter, Randomized Trial

Presenter: Shao-Liang Chen

October 25, 2023

Presentation TCT 2023

Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

Presenter: Robert Yeh

October 25, 2023

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

Presentation TCT 2023

TCT 279: Treatment of In-Stent Restenosis With Sirolimus- Versus Paclitaxel-Coated Balloons

Presenter: Matthias Bossard

October 24, 2023

Presentation TCT 2023

A Prospective, Multicenter, Randomized Trial Comparing Sirolimus-Coated Balloon with Paclitaxel-Coated Balloon in De-Novo Small Vessels: The TRANSFORM I Trial

Presenter: Patrick Serruys

October 24, 2023

Presentation TCT 2023

Treatment of Coronary De-Novo Lesions by a Sirolimus or a Paclitaxel Coated Balloon in a European Population

Presenter: Bruno Scheller

October 24, 2023

News Daily News

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

L.A. McKeown

July 11, 2023

News Industry News

Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

June 01, 2023

News Daily News

Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis

Michael O'Riordan

February 24, 2023

News Conference News

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

L.A. McKeown

November 18, 2022

News Conference News VIVA 2022

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

L.A. McKeown

November 03, 2022

News Industry News

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

September 13, 2022

Advertisement

Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis

TCTMD’s Top 10 Most Popular Stories for October 2023

TCT 128: Treatment of Coronary Artery Disease with Sirolimus- Versus Paclitaxel-Coated Balloons

Prevail Paclitaxel Coated Balloon

TCT 743: Long-term Clinical Outcomes of Paclitaxel-Coated Balloon Coronary Angioplasty: Data from the IRIS-DEB Registry

Comparing DCBs in De Novo CAD: Drugs, Design Matter

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

TCT 286: Comparison of Downstream Effect and Arterial Responses Among Sirolimus- and Paclitaxel-coated Balloons in Swine Heart Model

Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Drug-Eluting Stent In-Stent Restenosis: A Prospective, Multicenter, Randomized Trial

Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

TCT 279: Treatment of In-Stent Restenosis With Sirolimus- Versus Paclitaxel-Coated Balloons

A Prospective, Multicenter, Randomized Trial Comparing Sirolimus-Coated Balloon with Paclitaxel-Coated Balloon in De-Novo Small Vessels: The TRANSFORM I Trial

Treatment of Coronary De-Novo Lesions by a Sirolimus or a Paclitaxel Coated Balloon in a European Population

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content